Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
EVION GROUP NL | BAPA | Nov 13, 2024 | 0.02 | -2.94 |
Eviso SPA | 6Z8 | Nov 13, 2024 | 5.92 | -1.00 |
EVLI OYJ B | V6O | Nov 13, 2024 | 17.90 | -0.83 |
EVN AG | EVN | Nov 13, 2024 | 24.45 | -0.61 |
Evolent Health, Inc Class A | 9EH | Nov 13, 2024 | 13.60 | -3.55 |
Evolus, Inc. | EVL | Nov 13, 2024 | 11.60 | -4.92 |
Evolution | E3G1 | Nov 13, 2024 | 85.00 | +1.80 |
Evolution Energy Minerals Ltd | P77 | Nov 13, 2024 | 0.02 | -8.11 |
Evolution Mining Limited | WE7 | Nov 13, 2024 | 2.82 | -0.70 |
Evolution Petroleum Corporation, Inc. | EP7 | Nov 13, 2024 | 5.15 | -0.96 |
EVONIK INDS AG American Depositary Receipts - Unsponsored ( | EVKA | Nov 13, 2024 | 8.25 | -6.25 |
Evonik Industries AG | EVK | Nov 13, 2024 | 17.71 | -1.23 |
Evotec SE | EVT | Nov 13, 2024 | 8.46 | +2.11 |
EVOTEC SE ADR/2 O.N. | EVTA | Nov 13, 2024 | 4.20 | -1.41 |
EVS Broadcast Equipment SA | 5E1 | Nov 13, 2024 | 27.05 | -1.81 |
Exact Sciences Corporation | EXK | Nov 13, 2024 | 46.72 | -2.64 |
EXACT Therapeutics | 56F | Nov 13, 2024 | 0.48 | 0.00 |
Exagen Inc. | E08A | Nov 13, 2024 | 2.58 | -5.84 |
EXASOL AG NA O.N. | EXL | Nov 13, 2024 | 2.29 | +3.62 |
Excellence SA | 8XY | Nov 13, 2024 | 0.04 | 0.00 |
Excellon Resources Inc | E4X2 | Nov 13, 2024 | 0.06 | +6.09 |
Excelsior Mining Corp | 3XS | Nov 13, 2024 | 0.08 | -5.87 |
Exchange Income Corp | 0ON | Nov 13, 2024 | 37.00 | +1.09 |
Exclusive Networks SA | 97K | Nov 13, 2024 | 23.80 | +0.42 |
EXCO Technologies Ltd. | 3XT | Nov 13, 2024 | 5.60 | -0.89 |
Exedy Corporation | 64M | Nov 13, 2024 | 24.40 | +1.67 |
EXEL COMPOSITES OYJ | 8TY | Nov 13, 2024 | 0.28 | -1.43 |
Exel Industries | 8YK | Nov 13, 2024 | 45.60 | -1.72 |
Exelixis, Inc. | EX9 | Nov 13, 2024 | 34.01 | -0.06 |
Exelon Corporation | PEO | Nov 13, 2024 | 36.15 | +0.65 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.